CUMYL-THPINACA

CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-THPINACA acts as a potent agonist for the cannabinoid receptors, with approximately 6x selectivity for CB1, having an EC50 of 0.1nM for human CB1 receptors and 0.59nM for human CB2 receptors.

Legal status
Sweden's public health agency suggested to classify CUMYL-THPINACA as hazardous substance on November 10, 2014.

As of October 2015 CUMYL-THPINACA is a controlled substance in China.